Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.